Skip to main content

PROYECTANDO EL FUTURO DE LA PREDICCION GENETICA. DANDO FORMA A LOS IMAGINARIOS DE LA SUSCEPTIBILIDAD GENOMICA, UN ESTUDIO COMPARATIVO

PID2020-115899GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Testing Ecology: Breast and Gynecological Cancer Predisposition Tests and the National Healthcare System in Spain

  • Argudo-Portal, Violeta
[EN] This research asks what is being put to the test by breast and gynecological cancer predisposition testing in Spain beyond genes or cancer. By combining document analysis and fieldwork with national healthcare professionals and drawing on the anthropology and sociology of testing, I examine how the molecular relations of these tests extend to the political economy of the national healthcare system. I show how the capacity of these tests to produce a low-risk collective has paradoxical consequences for the political economy of the national healthcare system, unsettling professionals’ concerns and spotlighting what is prioritized in personalized medicine strategies., [ES] Esta investigación,desarrollada en el contexto español, se pregunta qué se pone a prueba con los test de predisposición al cáncer de mama y ginecológico más allá de los genes o el cáncer. Combinando el análisis documental y el trabajo de campo con profesionales del Sistema Nacional de Salud e inspirándome en la antropología y sociología de los test, exploro cómo las relaciones moleculares se extienden a la economía política del sistema sanitario. Muestro cómo la capacidad de estos test para producir un colectivo de bajo riesgo tiene consecuencias paradójicas en relación con la economía política sanitaria, inquieta al personal médico y pone en el punto de mira qué se prioriza en las estrategias de medicina personalizada., This work was supported by the Ifgene Project (MCIN/AEI/10.13039/501100011033 - ID PID2020-115899GB-I00, PI Mauro Turrini and Ruben Blanco) and by a Juan de la Cierva Fellowship (Grant FJC2021-046469-I funded by MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/PRTR, PI Violeta Argudo-Portal)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Let ‘Pregnant Women Choose the Destiny for Themselves and Their Child’. How Fertility Clinic Digital Platforms Frame Preimplantation Genetic Testing (PGT) in Spain

  • Turrini, Mauro
  • Otín-Gavín, Jorge
Preimplantation Genetic Testing (PGT) is used to select in vitro embryos for distinct clinical contexts and purposes. PGT for monogenic conditions (PGT-M), also known as Preimplantation Genetic Diagnosis (PGD), enables the prevention of passing on a known genetic disorder to one's offspring. Conversely, PGT for aneuploidies (PGT-A), or Preimplantation Genetic Screening (PGS), is used to improve IVF success rates in fertility patients and increase confidence about the health outcomes of potential offspring. Using discourse analysis, we examine how Spanish fertility clinic digital platforms frame these techniques and their associated subjectivity processes. We find: first, an excessively unproblematic portrayal of experimental innovations such as PGT; second, a linguistic, semantic and clinical overlap between ‘diagnosis’ and ‘screening’, which increases the genetic responsibility of couples or women without known genetic conditions regarding their prospective children; and third, the use of genomics as a modulator of female fertility and as a means to control maternal age-related decline. Ultimately, this discourse positions PGT as a routine IVF component, serving as an assurance tool for both treatment success and the health of the potential baby. This narrative reflects the speculative turn in assisted reproduction, emphasising new forms of responsibility and choice of would-be mothers., This study results from the project Projecting the Future of Genetic Prediction IfGene (ref. PID2020-115899GB-I00) funded by MICIU/AEI/10.13039/501100011033 (Ministry of Science, Innovation and Universities), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A perfect match: Expanded carrier screening in Spain's gamete economy

  • Turrini, Mauro
  • Argudo-Portal, Violeta
  • Pavone, Vincenzo
Some of the ideas developed in this article were first presented by M. Turrini and V. Pavone during the symposium “Mapping Genetic Screening Between Public Health and Personalized Medicine”, held at the Centro de Ciencias Humanas y Sociales in Madrid on November 23–24, 2023., This article examines how expanded carrier screening (ECS) – a genomic test based on whole-genome sequencing – has been integrated into Spain’s assisted reproductive technology sector. Marketed as a tool to enhance reproductive safety and personalization, ECS has become increasingly routinized within third-party gamete in vitro fertilization (IVF) through its use in genetic matching (GM), a technique that identifies shared genetic risks between donors and recipients. Drawing on qualitative data—including regulatory documents, professional guidelines, fertility clinic websites, and interviews with clinical experts—this study offers an analysis of how ECS has been localized, legitimized, and routinized in Spain’s ART sector. The central role of private actors in self-regulating ECS, similar to other innovative “add-ons”, has deepened the gap between public and private ART, the socio-economic stratification of the access to fertility services and further commercialized an already market-driven sector. Unlike other non-genetic add-ons, ECS-GM targets the pursuit of “healthy babies,” reshaping the responsibilities and expectations of clinics, recipients, and donors, and contributing to new forms of anticipatory care. Conceptualized through the lens of a “matching economy,” ECS-GM fuses donor anonymity with personalized selection by shifting the recipients’ choice from donor identity to selection techniques, taking an active role in what we name an “asymmetrical gamete matching economy.” This study contributes to critical debates on reproductive governance, marketization of genomic testing, and ethical politics of emerging biotechnologies, illustrating that reproductive technologies are embedded in institutional negotiations and molded by culturally and legally situated practices., Peer reviewed